Skip to content
Disclosery

Blue Capital, Inc.: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Blue Capital, Inc. on GSK, newest first. How the timeline and the estimate are built.

Blue Capital, Inc. held 4,556 GSK shares at 2026-09-30 per its 13F-HR filed 2026-10-13.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 4,556 shares
    Change vs previous 13F -31 shares

    0.14% of the 13F portfolio, value $219,464.

    13F-HR 0002032856-26-000009 filed by Blue Capital, Inc.
    Accepted , ingested

  2. period ended2026-06-30
    13F 4,587 shares
    Change vs previous 13F +687 shares

    0.15% of the 13F portfolio, value $240,451.

    13F-HR 0002032856-26-000007 filed by Blue Capital, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 3,900 shares
    Change vs previous 13F not available

    0.14% of the 13F portfolio, value $215,241.

    13F-HR 0002032856-26-000006 filed by Blue Capital, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).